United States · FDA National Drug Code directory
DAPAGLIFLOZIN
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 66993-457_10840285-52f3-4d61-800d-6e280488650e
- Product NDC
- 66993-457
- Form
- TABLET, FILM COATED
- Composition / generic term
- DAPAGLIFLOZIN
- Labeler
- Prasco Laboratories
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start / end (source format)
- 20240103
- Source listing expiry
- 20271231
Source-listed ingredients
- DAPAGLIFLOZIN PROPANEDIOL — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (66993-457-30) · 66993-457-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →